Pharmacologic Activation of Angiotensin-Converting Enzyme II Alleviates Diabetic Cardiomyopathy in db/db Mice by Reducing Reactive Oxidative Stress
Background Diabetes mellitus is one of the most common chronic diseases worldwide, and cardiovascular disease is the leading cause of morbidity and mortality in diabetic patients. Diabetic cardiomyopathy (DCM) is a phenomenon characterized by a deterioration in cardiac function and structure, indepe...
Main Authors: | Donghyun Kim, Wooju Jeong, Yumin Kim, Jibeom Lee, Sung Woo Cho, Chang-Myung Oh, Raekil Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2023-07-01
|
Series: | Diabetes & Metabolism Journal |
Subjects: | |
Online Access: | http://e-dmj.org/upload/pdf/dmj-2022-0125.pdf |
Similar Items
-
Diminazene aceturate mitigates cardiomyopathy by interfering with renin-angiotensin system in a septic rat model
by: Zhaoqing Lu, et al.
Published: (2022-07-01) -
DAD3 targets ACE2 to inhibit the MAPK and NF-κB signalling pathways and protect against LPS-induced inflammation in bovine mammary epithelial cells
by: Xiangjun Zhang, et al.
Published: (2022-12-01) -
Diminazen Aceturate Protects Pulmonary Ischemia-Reperfusion Injury via Inhibition of ADAM17-Mediated Angiotensin-Converting Enzyme 2 Shedding
by: Li-Fang Wang, et al.
Published: (2021-10-01) -
Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2
by: John M. Matsoukas, et al.
Published: (2022-07-01) -
Association of exercise training and angiotensin-converting enzyme 2 activator improves baroreflex sensitivity of spontaneously hypertensive rats
by: P.R. Lopes, et al.
Published: (2016-08-01)